News · Heart & Metabolic
Each 20-point drop in blood pressure tracked 24% fewer kidney failure deaths
Kidney disease kills more people in Mexico than almost anywhere, and blood pressure was suspected rather than measured. Following 133,470 adults in Mexico City, the relationship ran in a straight line with no threshold to hide under.
- Every 20-point fall in the upper blood pressure reading tracked 24% fewer kidney deaths.
- The line was straight, with no safe level below which the benefit stopped.
- High blood pressure accounted for about 9% of all kidney failure deaths.
- The link was stronger in people without diabetes than in people with it.
- 133,470 adults recruited in Mexico City and followed for decades.
Blood pressure is discussed almost entirely as a heart problem. The campaigns are about strokes and heart attacks, the drugs are prescribed by cardiologists as often as anyone, and the organ quietly doing the most work under high pressure barely features.
Kidneys filter the entire blood volume many times a day through vessels fine enough to be damaged by the force pushing blood through them. Chronic kidney disease is a major cause of death in Mexico, at rates well above comparable countries, and how much of that is pressure has been assumed rather than measured.
Writing in the American Journal of Kidney Diseases, researchers followed 133,470 adults recruited from two districts of Mexico City and measured it. Previously the contribution of blood pressure to that death toll had been estimated rather than counted.
A straight line, not a threshold
The relationship had no cliff edge in it. Systolic blood pressure showed a continuous log-linear association with kidney failure mortality, meaning risk fell by a steady proportion for every equal step down in pressure.
Each 20 mm Hg lower systolic pressure carried 24% lower risk of dying from kidney failure between the ages of 40 and 84. The diastolic reading behaved the same way.
The absence of a threshold is the practically important part. Guidelines draw a line at 140 over 90 and call everything below it normal, and a straight line means the person at 135 is still carrying more risk than the person at 115. There is no reading low enough to stop mattering.
What it adds up to across a population
Individually the effect is a gradient. Collectively it is a large number of deaths.
Hypertension accounted for 9% of kidney failure deaths in this population. Roughly one in eleven, from a cause that is cheap to detect, cheap to treat and usually symptomless until late.
That figure is the argument for treating blood pressure as a kidney intervention rather than only a cardiac one, particularly in a country where kidney failure kills at the rate it does in Mexico.
The diabetes result that reads backwards
The association was stronger among those without diabetes than with diabetes, which sounds like blood pressure matters less to the people most at risk. It does not mean that.
The relative reduction was larger in people without diabetes and the absolute excess risk associated with higher pressure was similar in both groups. Diabetes supplies a second, powerful route to kidney failure that operates regardless of pressure, so pressure accounts for a smaller share of a much larger total.
Same number of deaths attributable to pressure, expressed against a bigger denominator. It is a statistical artifact of how proportions work, not a clinical instruction to relax about blood pressure in diabetes, where it remains among the most important things to control.
What the design can and cannot support
Everyone included was free of kidney disease and other chronic illness at recruitment, apart from diabetes, and had to survive five years afterwards. That exclusion window is deliberate: it removes people whose blood pressure was already being driven by kidney disease nobody had yet found.
It does not remove all of them. The authors are direct about the gap: baseline urine samples were unavailable and kidney function trends over time could not be assessed. Protein in the urine is the earliest sign of kidney damage, and without it at baseline, some quiet existing disease will have traveled into the analysis.
A random subset of 9,198 was re-examined more than a decade later, which is how the study could look at kidney function and albuminuria as well as death.
Why a Mexican cohort answers a general question
Kidney failure is not evenly distributed. Mexico carries one of the heaviest burdens in the world, for reasons involving diabetes prevalence, heat, occupational exposure and access to care, and the causes are still argued about.
A cohort that size in that setting can measure the contribution of one factor against a background where the outcome is common enough to count properly. In a population where kidney failure deaths are rarer, the same study would need to be far larger to say anything.
The gradient it describes is not specific to Mexico. What is specific is how much damage that gradient does when it acts on a population already at high risk.
The takeaway
Blood pressure is a kidney number as much as a heart number, and it behaves the same way in both: lower is better, continuously, with no point at which the benefit runs out.
For anyone whose reading sits in the range doctors describe as fine, that is the useful correction. Fine is a comparison with other people, not a statement about what is happening to the vessels in an organ that never stops filtering.
People also ask
What did the study find?
Systolic blood pressure showed a continuous log-linear association with kidney failure mortality, with each 20 mm Hg lower systolic pressure associated with 24% lower risk at ages 40-84 (HR 0.76, 95% CI 0.69-0.84). Results were similar for diastolic pressure, and hypertension accounted for 9% of kidney failure deaths.
What does log-linear mean here?
That risk falls by a constant proportion for each equal step down in pressure, across the whole range studied. There is no point at which the benefit stops or a threshold below which pressure no longer matters.
Why was the association weaker in people with diabetes?
The relative reduction was smaller in that group (HR 0.90) than in people without diabetes (HR 0.54), but the absolute excess risk associated with higher pressure was similar. Diabetes supplies its own large, independent route to kidney failure, which dilutes the proportion attributable to pressure without reducing the number of deaths involved.
Why study this in Mexico?
Because chronic kidney disease is a major cause of death there, at rates far above most comparable countries, and the reasons are not fully understood. A large cohort in that setting can measure how much of the burden blood pressure accounts for.
Does this prove lowering blood pressure saves kidneys?
Not on its own; this is an observational cohort. It is consistent with trial evidence that blood pressure lowering slows kidney disease, and its contribution is quantifying how much of the death toll is attributable to pressure in a high-burden population.
What are the study's limits?
The authors note that baseline urine samples were unavailable and kidney function trends over time could not be assessed, so early kidney damage present at recruitment cannot be ruled out as a contributor.
What is the practical point?
That blood pressure control is kidney protection as well as heart protection, and that there is no reading low enough to stop caring about. Treatment decisions belong with a clinician. This is general information rather than medical advice.